Methods for time-varying exposure related problems in pharmacoepidemiology: An overview-Reference-Cited by-同舟云学术

Methods for time-varying exposure related problems in pharmacoepidemiology: An overview

Published:2017-12-28 Issue:2 Volume:27 Page:148-160
ISSN:1053-8569
Container-title:Pharmacoepidemiology and Drug Safety
language:en
Short-container-title:Pharmacoepidemiol Drug Saf

Author:

Pazzagli Laura¹^ORCID,Linder Marie¹,Zhang Mingliang²,Vago Emese²,Stang Paul²,Myers David²,Andersen Morten¹³,Bahmanyar Shahram¹

Affiliation:

1. Centre for Pharmacoepidemiology, Department of Medicine; Karolinska Institutet; Stockholm Sweden

2. Janssen; Beerse Belgium

3. Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences; University of Copenhagen; Denmark

Funder

Novo Nordisk

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pds.4372/fullpdf

Reference51 articles.

1. Construction of drug treatment episodes from drug-dispensing histories is influenced by the gap length;Gardarsdottir;J Clin Epidemiol,2010

2. Marginal structural models and causal inference in epidemiology;Robins;Epidemiology,2000

3. Immediate and delayed impact of oral glucocorticoid therapy on risk of serious infection in patients with rheumatoid arthritis: a nested case-control analysis using a weighted cumulative dose model;Dixon;Arthritis Rheum,2011

4. Adjusting for treatment switching in randomised controlled trials-a simulation study and a simplified two-stage method;Latimer;Stat Methods Med Res,2014

5. Correcting overall survival for the impact of crossover via a rank-preserving structural failure time (Rpsft) model in the Record-1 trial of everolimus in metastatic renal-cell carcinoma;Korhonen;J Biopharm Stat,2012

Cited by 83 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outcomes of Patients with COPD Treated with ICS/LABA Before and After Initiation of Single-Inhaler Triple Therapy with Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI);Advances in Therapy;2024-02-04

2. Assessing cumulative effects of medication use: New insights and new challenges;Pharmacoepidemiology and Drug Safety;2023-12-27

3. Major adverse cardiovascular events of enzalutamide versus abiraterone in prostate cancer: a retrospective cohort study;Prostate Cancer and Prostatic Diseases;2023-12-05

4. Reporting, handling, and interpretation of time‐varying drug treatments in observational studies using routinely collected healthcare data;Journal of Evidence-Based Medicine;2023-12

5. Non-Adherence to COPD Medications and its Association with Adverse Events: A Longitudinal Population Based Cohort Study of Older Adults;Annals of Epidemiology;2023-12